Detalhe da pesquisa
1.
DOTA-Based Plectin-1 Targeted Contrast Agent Enables Detection of Pancreatic Cancer in Human Tissue.
Angew Chem Int Ed Engl;
63(26): e202318485, 2024 Jun 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38608197
2.
Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer.
Cell Rep Med;
3(11): 100815, 2022 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36384095